Careers Header Bg
Regask Raps Edts 2025 Landing Page
REGASK SPONSORS

RAPS European Digital Technology and Software Conference 2025

OCTOBER 30-31, 2025  | Rotterdam, Netherlands

Hilton Rotterdam Weena 10

Meet us at RAPS EDTS Conference 2025 Meet us at DIA Singapore 2025

Meet our team

Join Kelli Madden, Senior Regulatory Intelligence Manager, and Oliver Stein, Business Development Director, as they represent RegASK at the RAPS European Digital Technology & Software Conference (EDTS) 2025 in Rotterdam, Netherlands.

Connect with our experts to discover how AI-driven regulatory intelligence and workflow orchestration are reshaping the future of regulatory affairs—empowering organizations to navigate complexity, accelerate compliance, and drive digital transformation across the life sciences industry.

Raps Edts Rotterdam 2025 Attendees

Oliver Stein

Business Development Director

Kelli Madden

Senior Regulatory Intelligence Manager



Bg Flip Card 1

RAPS European Digital Technology and Software Conference 2025

The 2025 RAPS European Digital Technology & Software Conference (EDTS) is a premier event dedicated to the intersection of digital innovation and regulatory affairs in healthcare. Scheduled for 30–31 October 2025 at the Hilton Rotterdam, this conference offers a platform for regulatory professionals to engage with the latest advancements in AI, software, and digital technologies impacting medical devices, IVDs, and pharmaceuticals.

Through expert-led sessions and collaborative discussions, attendees will explore the evolving regulatory landscape, focusing on the integration of emerging technologies and their implications for compliance and innovation.

Key Themes Include:

  • Regulatory strategies for AI and software in healthcare
  • Navigating digital transformation in medical devices and IVDs
  • Ensuring data integrity and cybersecurity in digital health solutions
  • Adapting to regulatory changes in the digital era

Venue & Schedule:
📍 Hilton Rotterdam
Weena 10, 3012 CM, Rotterdam, Netherlands
🗓 30–31 October 2025
09:00 – 17:00 CET

What RegASK Brings to RAPS EDTS 2025

At RegASK, we’re shaping the future of regulatory affairs with AI-driven intelligence and workflow orchestration. We help organizations monitor evolving regulations, streamline global-to-local workflows, anticipate risks, and accelerate compliance decisions with confidence and precision.

🎙 Speaking Session
Kelli Madden, Senior Regulatory Intelligence Manager at RegASK
🕒 12:15 PM – 1:15 PM | Thursday, 30 October 2025
Topic: “Navigating the Future of Regulatory Affairs: Technology-Driven Strategies for Enhanced Intelligence and Workflow”

Join this session to discover how emerging technologies are redefining regulatory intelligence, empowering teams to enhance compliance agility, optimize decision-making, and drive innovation in an increasingly complex regulatory landscape.

Meet us at RAPS EDTS Conference 2025

Our solution

RegASK leverages advanced AI and machine learning to help businesses in highly regulated industries streamline their regulatory compliance processes and stay ahead of the curve. Our cutting-edge solution automates regulatory research, provides vital insights, and empowers regulatory affairs teams to become strategic partners in driving business growth.

Resources

Navigating a Potential U.S. Government Shutdown: Implic…
As legislators in Washington, DC, face a critical March 14th deadline to finalize federal spending, the possibility of a U.S. government shu…
Read more
RegASK Featured in Gartner’s Market Guide for Regulat…
We’re thrilled to share that RegASK has been included in Gartner’s Market Guide for Regulatory Intelligence Solutions! This recognition …
Read more
The 2025 State of Regulatory Affairs and Compliance Rep…
Is your organization prepared for 2025’s regulatory complexities? The regulatory landscape in 2025 is more complex than ever, with new adv…
Read more
ANSM (France) Clarifies CE Mark Exemption Process for M…
On January 27, 2025, the National Security Agency of Medicines and Health Products (ANSM) in France issued a key update regarding the proces…
Read more
US FDA Announces Draft Guidance on AI Use in Regulatory…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of a draft guidance titled “Considerations for the U…
Read more
US FDA Announces Public Meeting on Paediatric Legislati…
The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting: Implementation of the Best Pharm…
Read more
FDA (USA) Establishes New Center for Real-World Evidenc…
On December 12, 2024, the U.S. Food and Drug Administration (FDA) announced the creation of the Center for Real-World Evidence and Innovatio…
Read more
Portuguese Industry Opposes U.S. Proposal for Cancer Wa…
The United States Health Authority is considering the introduction of mandatory cancer warning labels on alcoholic beverages, a measure simi…
Read more